Atrial natriuretic peptides in plasma

Clinica Chimica Acta

Volumn 443, Issue , 2015, Pages 25-28

  Goetze, Jens P ^a   Hansen, Lasse H ^a   Terzic, Dijana ^a   Zois, Nora E ^a   Albrethsen, Jakob ^a   Timm, Annette ^a   Smith, Julie ^a   Soltysinska, Ewa ^a   Lippert, Solvej K ^a   Hunter, Ingrid ^a  

^a Rigshospitalet   (Denmark)

Author keywords

ABP; BNP; CNP; Heart failure; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; PRO ATRIAL NATRIURETIC PEPTIDE; PRO BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PROCESSING; BLOOD; HEART FAILURE;

ATRIAL NATRIURETIC FACTOR; HEART FAILURE; HUMANS;

EID: 84924258109     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.08.017     Document Type: Article

References (36)

1. Nishikimi T., Minamino N., Nakao K. Diverse molecular forms of plasma B-type natriuretic peptide in heart failure. Curr Heart Fail Rep 2011, 8:140-146.
2. Goetze J.P. B-type natriuretic peptide: from posttranslational processing to clinical measurement. Clin Chem 2012, 58:83-91.
3. Clerico A., Vittorini S., Passino C. Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. Adv Clin Chem 2012, 58:31-44.
4. de Bold A.J., Borenstein H.B., Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981, 28:89-94.
5. Flynn T.G., de Bold M.L., de Bold A.J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983, 117:859-865.
6. Nakao K., Morii N., Itoh H., Yamada T., Shiono S., Sugawara A., et al. Atrial natriuretic polypeptide in the brain: implication of central cardiovascular control. J Hypertens Suppl 1986, 4:S492-S496.
7. Vollmar A.M. Atrial natriuretic peptide in peripheral organs other than the heart. Klin Wochenschr 1990, 68:699-708.
8. Vuolteenaho O., Arjamaa O., Vakkuri O., Maksniemi T., Nikkilä L., Kangas J., et al. Atrial natriuretic peptide (ANP) in rat gastrointestinal tract. FEBS Lett 1988, 233:79-82.
9. Gutkowska J., Bourassa M., Roy D., Thibault G., Garcia R., Cantin M., et al. Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma. Biochem Biophys Res Commun 1985, 128:1350-1357.
10. Burnett J.C., Kao P.C., Hu D.C., Heser D.W., Heublein D., Granger J.P., et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986, 231:1145-1147.
11. Cernacek P., Crawhall J.C., Levy M. Atrial natriuretic peptide: blood levels in human disease and their measurement. Clin Biochem 1988, 21:5-17.
12. Steiner D.F. The proinsulin C-peptide-a multirole model. Exp Diabesity Res 2004, 5:7-14.
13. Buckley M.G., Sagnella G.A., Markandu N.D., Singer D.R., MacGregor G.A. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure. Clin Sci (Lond) 1989, 77:573-579.
14. Buckley M.G., Sagnella G.A., Markandu N.D., Singer D.R., MacGregor G.A. Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form. Clin Chim Acta 1990, 191:1-14.
15. Hall C., Aaberge L., Stokke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995, 91:911.
16. Morgenthaler N.G., Struck J., Thomas B., Bergmann A. Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 2004, 50:234-236.
17. Maisel A., Mueller C., Nowak R., Peacock W.F., Landsberg J.W., Ponikowski P., et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010, 55:2062-2076.
18. Lauridsen B.K., Iversen K., Hunter I., Bay M., Kirk V., Nielsen O.W., et al. ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study. BMJ Open 2013, 3:e003288. 10.1136/bmjopen-2013-003288.
19. Asferg C.L., Nielsen S.J., Andersen U.B., Linneberg A., Møller D.V., Hedley P.L., et al. Metabolic rather than body composition measurements are associated with lower serum natriuretic peptide concentrations in normal weight and obese men. Am J Hypertens 2014, 27:620-627.
20. Buglioni A., Burnett J.C. A gut-heart connection in cardiometabolic regulation. Nat Med 2013, 19:534-536.
21. Zois N.E., Bartels E.D., Hunter I., Kousholt B.S., Olsen L.H., Goetze J.P. Natriuretic peptides in cardiometabolic regulation and disease. Nat Rev Cardiol May 13 2014, [Epub ahead of print]. 10.1038/nrcardio.2014.64.
22. Rehfeld J.F., Goetze J.P. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 2003, 3:25-38.
23. Goetze J.P., Kastrup J., Pedersen F., Rehfeld J.F. Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 2002, 48:1035-1042.
24. Hunter I., Rehfeld J.F., Goetze J.P. Measurement of the total proANP product in mammals by processing independent analysis. J Immunol Methods 2011, 370:104-110.
25. Pemberton C.J., Siriwardena M., Kleffmann T., Ruygrok P., Palmer S.C., Yandle T.G., et al. First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: initial assessment as cardiovascular biomarkers. Clin Chem 2012, 58:757-767.
26. Kim M.S., Pinto S.M., Getnet D., Nirujogi R.S., Manda S.S., Chaerkady R., et al. A draft map of the human proteome. Nature 2014, 509(7502):575-581.
27. Sugawara A., Nakao K., Morii N., Yamada T., Itoh H., Shiono S., et al. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. J Clin Invest 1988, 81:1962-1970.
28. Yan W., Sheng N., Seto M., Morser J., Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 1999, 274:14926-14935.
29. Wu F., Wu Q. Corin-mediated processing of pro-atrial natriuretic peptide in human small cell lung cancer cells. Cancer Res 2003, 63:8318-8322.
30. Dries D.L., Victor R.G., Rame J.E., Cooper R.S., Wu X., Zhu X., et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 2005, 112:2403-2410.
31. Beaubien G., Schäfer M.K., Weihe E., Dong W., Chrétien M., Seidah N.G., et al. The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res 1995, 279:539-549.
32. Schellenberger U., O'Rear J., Guzzetta A., Jue R.A., Protter A.A., Pollitt N.S. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006, 451:160-166.
33. Tonne J.M., Campbell J.M., Cataliotti A., Ohmine S., Thatava T., Sakuma T., et al. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Clin Chem 2011, 57:864-873.
34. Hunter I., Alehagen U., Dahlström U., Rehfeld J.F., Crimmins D.L., Goetze J.P. N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification. Clin Chem 2011, 57:1327-1330.
35. Luckenbill K.N., Christenson R.H., Jaffe A.S., Mair J., Ordonez-Llanos J., Pagani F., et al. Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 2008, 54:619-621.
36. Hunter I., Goetze J.P. Next generation natriuretic peptide measurement. Adv Clin Chem 2012, 58:45-48.